Machida, Japan

Ryoichi Ando


Average Co-Inventor Count = 5.2

ph-index = 6

Forward Citations = 61(Granted Patents)


Location History:

  • Machida, JP (1994 - 1998)
  • Kanagawa, JP (1995 - 2007)
  • Tokyo, JP (2005 - 2008)

Company Filing History:


Years Active: 1994-2008

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Ryoichi Ando: Innovator in Pyrimidone Derivatives

Introduction

Ryoichi Ando is a notable inventor based in Machida, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of pyrimidone derivatives. With a total of 12 patents to his name, Ando's work focuses on innovative solutions for neurodegenerative diseases.

Latest Patents

Among his latest patents, Ando has developed a series of 2-amino-3-(alkyl)-pyrimidone derivatives. These compounds are represented by a specific formula and include a medicament that utilizes these derivatives as an active ingredient. This medicament is aimed at the preventive and therapeutic treatment of neurodegenerative diseases, particularly those caused by abnormal activity of GSK3β, such as Alzheimer's disease. Additionally, he has worked on other pyrimidone derivatives that target diseases caused by tau protein kinase 1 hyperactivity, also related to Alzheimer's disease.

Career Highlights

Throughout his career, Ryoichi Ando has been associated with prominent companies such as Mitsubishi Kasei Corporation and Mitsubishi Chemical Corporation. His work in these organizations has allowed him to advance his research and contribute to the development of innovative medicinal products.

Collaborations

Ando has collaborated with several notable individuals in his field, including Yasuhiro Morinaka and Chizuko Takahashi. These collaborations have further enriched his research and development efforts.

Conclusion

Ryoichi Ando's contributions to the field of medicinal chemistry, particularly through his patents on pyrimidone derivatives, highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of neurodegenerative diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…